Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
2022
Africa
Europe
Western Pacific
Clear all
Type of publications
NITAG documentation
(42)
Systematic reviews (SYSVAC)
(32)
Topics
Available to download in languages
Regions
Africa
(23)
Europe
(34)
Western Pacific
(17)
Americas
(39)
Eastern Mediterranean
(3)
South-East Asia
(1)
Countries
Algeria
(1)
Australia
(11)
Belgium
(5)
Burkina Faso
(1)
China
(6)
Ethiopia
(6)
France
(9)
Germany
(2)
Ireland
(4)
Italy
(1)
Netherlands
(1)
Niger
(1)
Nigeria
(1)
Spain
(1)
Uganda
(3)
Ukraine
(1)
United Kingdom
(6)
Diseases
COVID-19
(74)
Hepatitis B
(3)
Herpes zoster
(3)
Human papillomavirus (HPV)
(9)
Influenza
(5)
Japanese encephalitis
(1)
Malaria
(4)
Meningococcal disease
(1)
Mpox // Monkeypox
(9)
Pertussis
(1)
Pneumococcal disease
(6)
Poliomyelitis
(1)
Rabies
(1)
Rotavirus
(2)
Typhoid
(1)
Vaccine topics
Acceptance
(22)
Coverage
(6)
Economic aspects
(1)
Efficacy/effectiveness
(1)
Ethical issues
(4)
Safety
(1)
Target population
Adolescents
(4)
Adults
(13)
All age groups
(18)
Children
(6)
Healthcare workers
(17)
Newborn
(2)
Older adults
(5)
Parents/caregivers
(4)
Pregnant women
(5)
Travellers
(1)
Publication date
2022
(74)
2024
(1)
2023
(27)
2021
(107)
2020
(37)
74 results found
2022
∙
Chen, H. Zhang, X. Lin, G. Gong, F. Hocher, B.
Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review
2022
∙
Ludvigsson, J. F. Loboda, A.
Systematic review of health and disease in Ukrainian children highlights poor child health and challenges for those treating refugees
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the VLA2001 vaccine
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the VidPrevtyn Beta vaccine
2022
∙
Haute Autorité de Santé
Booster vaccine strategy against Covid-19
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the Nuvaxovid vaccine in the booster strategy
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: role of the bivalent Spikevax Original / Omicron BA.4/BA.5 vaccine (mRNA-1273.222)
2022
∙
ATAGI
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 with mRNA vaccines for children from 6 months of age in Belgium
2022
∙
ATAGI
ATAGI recommendations for a booster dose of the paediatric Pfizer COVID-19 vaccine in children aged 5 to 11 years
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register